TAFAZZIN and Barth syndrome: Similarly, Chowdhury et al. recently showed evidence of increased glycolytic activity and reduced FAO in heart tissue from a tafazzin-mutant knock-in mouse model of BTHS, as well as in tafazzin-mutant iPSC-derived cardiomyocytes and TAZ-KO mouse embryonic fibroblasts41.